Development of novel fluorinated reagents for preparation of drugs.

Informations projet

FLUNOVELTY

N° de convention de subvention: 654260

DOI 10.3030/654260

Projet clôturé

Date de signature de la CE 26 Mars 2015

Date de début 1 Novembre 2015

Date de fin 31 Octobre 2016

Financé au titre de

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Coût total € 92 538,00

Contribution de l’UE € 92 538,00

Coordonné par

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS
France

Objectif

Around 20% of all modern drugs are fluorinated organic molecules. During the recent years, however, pharmaceutical companies struggle to deliver novel drugs to the market, because of the lack of innovative practical reagents and reactions towards “drug-like” compounds.
In this project, we will address this issue by discovering novel small fluorinating reagents - fluorinated diazoalkanes, - elaborate their practical reactions, and use this knowledge to develop alternative synthetic approaches to some known drugs (AS-136A, Celecoxib).

Champ scientifique

• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programme(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Thème(s)

• MSCA-IF-2014-EF - Marie Skłodowska-Curie Individual Fellowships (IF-EF)

Appel à propositions

H2020-MSCA-IF-2014

Régime de financement

MSCA-IF-EF-ST - Standard EF

Coordinateur

ECOLE SUPERIEURE DE PHYSIQUE ET DECHIMIE INDUSTRIELLES DE LA VILLE DEPARIS

• Contribution nette de l'UE: € 92 538,00
• Adresse: RUE VAUQUELIN 10 ; 75231 Paris ; France
• Région: Ile-de-France › Ile-de-France › Paris
• Type d’activité: Higher or Secondary Education Establishments
• Coût total: € 92 538,00